|Articles|May 1, 2019

EVERSANA and OptimizeRx Partnership

EVERSANA, an independent provider of global services to the life science industry, and OptimizeRx Corp., a digital health messaging platform focused on affordability and adherence, announced their partnership to integrate a real-time electronic health records (EHR) network and patient services to progress access and adherence for patients.

OptimizeRx’s real-time EHR network will integrate into EVERSANA’s patient support and specialty distribution models to expedite the process from diagnosis and enrollment to affordability solutions and ongoing patient support.

The EHR and patient support service integration will reduce the need for manual, paper-based processing, expedite enrollments, quickly identify affordability and copay programs, and drive proactive adherence support services offered by both the provider and specialty HUB services.

 


Related to this article

Pharmaceutical Executive Daily
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.